Apyx Medical Corp
NASDAQ:APYX
Apyx Medical Corp
NASDAQ:APYX
Price:
3.89
USD
-1.27%
Market Closed
Market Cap:
$162.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Apyx Medical Corp
NASDAQ:APYX
|
US |
|
Gujarat Industries Power Company Ltd
BSE:517300
|
IN |
|
SEMrush Holdings Inc
NYSE:SEMR
|
US |
|
P
|
Perma Plasindo Tbk PT
IDX:BINO
|
ID |
|
W
|
Worthington Group PLC
LSE:WRN
|
UK |
|
TDG Holding Co Ltd
SSE:600330
|
CN |
|
Semiconductor Manufacturing International Corp
HKEX:981
|
CN |
|
A
|
AG Mortgage Investment Trust Inc
NYSE:MITT
|
US |
|
S
|
Satellos Bioscience Inc
XTSX:MSCL
|
CA |
|
ICL Group Ltd
NYSE:ICL
|
IL |
|
A-One Seimitsu Inc
TSE:6156
|
JP |
Balance Sheet
Balance Sheet Decomposition
Apyx Medical Corp
Apyx Medical Corp
Balance Sheet Decomposition is not available for
Apyx Medical Corp
Apyx Medical Corp
Balance Sheet
Apyx Medical Corp
Apyx Medical Corp
Currency: USD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
2
|
1
|
3
|
4
|
3
|
2
|
4
|
5
|
4
|
8
|
6
|
12
|
14
|
10
|
17
|
59
|
42
|
31
|
10
|
44
|
32
|
32
|
|
| Cash Equivalents |
0
|
0
|
2
|
1
|
3
|
4
|
3
|
2
|
4
|
5
|
4
|
8
|
6
|
12
|
14
|
10
|
17
|
59
|
42
|
31
|
10
|
44
|
32
|
32
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
62
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
3
|
2
|
2
|
3
|
5
|
5
|
5
|
9
|
17
|
21
|
18
|
14
|
16
|
17
|
|
| Accounts Receivables |
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
3
|
2
|
2
|
3
|
5
|
5
|
4
|
8
|
8
|
13
|
11
|
14
|
16
|
17
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
9
|
8
|
8
|
0
|
0
|
0
|
|
| Inventory |
2
|
2
|
2
|
3
|
4
|
5
|
5
|
7
|
8
|
8
|
8
|
8
|
6
|
6
|
6
|
7
|
3
|
5
|
4
|
7
|
12
|
10
|
8
|
9
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
3
|
4
|
3
|
2
|
3
|
3
|
2
|
1
|
|
| Total Current Assets |
5
|
5
|
7
|
7
|
10
|
12
|
12
|
13
|
15
|
16
|
16
|
20
|
15
|
22
|
27
|
23
|
90
|
77
|
66
|
61
|
43
|
70
|
56
|
58
|
|
| PP&E Net |
2
|
2
|
2
|
3
|
3
|
3
|
7
|
9
|
7
|
7
|
7
|
7
|
7
|
7
|
6
|
6
|
6
|
8
|
7
|
7
|
8
|
7
|
7
|
7
|
|
| PP&E Gross |
2
|
2
|
2
|
3
|
3
|
3
|
7
|
9
|
7
|
7
|
0
|
7
|
7
|
0
|
0
|
6
|
6
|
8
|
7
|
7
|
8
|
7
|
7
|
7
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
2
|
2
|
3
|
4
|
4
|
4
|
5
|
0
|
6
|
6
|
0
|
0
|
7
|
6
|
4
|
5
|
5
|
5
|
4
|
4
|
4
|
|
| Intangible Assets |
1
|
2
|
2
|
2
|
3
|
4
|
5
|
5
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
2
|
3
|
4
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9
N/A
|
9
+10%
|
11
+19%
|
12
+5%
|
17
+42%
|
19
+14%
|
27
+40%
|
27
+3%
|
28
+1%
|
28
+2%
|
28
0%
|
33
+18%
|
25
-25%
|
31
+27%
|
35
+12%
|
31
-12%
|
96
+210%
|
85
-12%
|
74
-13%
|
69
-7%
|
52
-25%
|
79
+53%
|
65
-18%
|
67
+3%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
4
|
6
|
8
|
6
|
9
|
6
|
10
|
7
|
8
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
0
|
1
|
1
|
|
| Total Current Liabilities |
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
5
|
6
|
9
|
12
|
9
|
13
|
12
|
13
|
11
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
33
|
34
|
35
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
6
|
13
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
6
|
6
|
5
|
|
| Total Liabilities |
2
N/A
|
2
-3%
|
2
-2%
|
2
+3%
|
3
+34%
|
2
-8%
|
6
+163%
|
6
+1%
|
6
-6%
|
6
+2%
|
5
-14%
|
12
+124%
|
20
+70%
|
8
-60%
|
9
+11%
|
9
+1%
|
9
-2%
|
13
+54%
|
10
-23%
|
15
+45%
|
14
-6%
|
53
+270%
|
51
-4%
|
52
+3%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
13
|
11
|
11
|
8
|
6
|
2
|
2
|
3
|
3
|
3
|
10
|
28
|
19
|
23
|
29
|
34
|
15
|
3
|
13
|
36
|
54
|
78
|
89
|
|
| Additional Paid In Capital |
20
|
20
|
20
|
21
|
22
|
22
|
23
|
23
|
25
|
25
|
26
|
29
|
29
|
43
|
50
|
51
|
53
|
57
|
61
|
66
|
73
|
81
|
92
|
104
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
7
+15%
|
9
+24%
|
10
+6%
|
14
+43%
|
17
+18%
|
20
+22%
|
21
+3%
|
22
+4%
|
22
+2%
|
23
+4%
|
21
-7%
|
5
-78%
|
23
+399%
|
26
+12%
|
22
-16%
|
87
+296%
|
71
-18%
|
64
-11%
|
54
-16%
|
38
-30%
|
27
-29%
|
14
-47%
|
15
+2%
|
|
| Total Liabilities & Equity |
9
N/A
|
9
+10%
|
11
+19%
|
12
+5%
|
17
+42%
|
19
+14%
|
27
+40%
|
27
+3%
|
28
+1%
|
28
+2%
|
28
0%
|
33
+18%
|
25
-25%
|
31
+27%
|
35
+12%
|
31
-12%
|
96
+210%
|
85
-12%
|
74
-13%
|
69
-7%
|
52
-25%
|
79
+53%
|
65
-18%
|
67
+3%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
13
|
13
|
14
|
14
|
15
|
15
|
17
|
17
|
18
|
18
|
18
|
18
|
18
|
27
|
31
|
33
|
34
|
34
|
34
|
34
|
35
|
35
|
38
|
42
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
